Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Amgen Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
AMGN
Nasdaq
2830
www.amgen.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Amgen Inc.
Here’s Why Amgen Inc. (AMGN) Is Among the Highest Yielding Dividend Stocks In the Dow
- Jan 19th, 2025 11:19 pm
Why Amgen Inc. (AMGN) Is One of the Best Cheap Stocks to Buy for 2025?
- Jan 19th, 2025 12:05 am
Why Is Amgen Inc. (AMGN) Among Louis Navellier’s Top Long-term Stock Picks?
- Jan 18th, 2025 4:03 pm
Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
- Jan 18th, 2025 1:20 pm
Amgen (AMGN) Rises Yet Lags Behind Market: Some Facts Worth Knowing
- Jan 17th, 2025 10:50 pm
FDA APPROVES LUMAKRAS® (SOTORASIB) IN COMBINATION WITH VECTIBIX® (PANITUMUMAB) FOR CHEMOREFRACTORY KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER
- Jan 17th, 2025 2:01 pm
FDA Greenlights Amgen's New Cancer Drug Combo, Boosting Survival for KRAS G12C Patients
- Jan 17th, 2025 1:11 pm
Is Amgen Inc. (AMGN) Among the Best NASDAQ Dividend Stocks to Buy?
- Jan 16th, 2025 6:03 pm
2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows
- Jan 16th, 2025 1:00 pm
NVO, VKTX Stocks Fall as Lilly's Zepbound, Mounjaro Sales Slow Down
- Jan 15th, 2025 6:30 pm
Amgen (AMGN) Stock Falls Amid Market Uptick: What Investors Need to Know
- Jan 14th, 2025 11:00 pm
JPM25: Amgen’s defense, Merck’s patent ‘hill’ and Viking’s long-term planning
- Jan 14th, 2025 6:04 pm
Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term
- Jan 14th, 2025 2:50 pm
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
- Jan 14th, 2025 2:00 pm
Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows.
- Jan 14th, 2025 12:25 pm
JP Morgan 2025: reduced dosing and expanded manufacturing paving way for Amgen’s obesity entrance
- Jan 14th, 2025 12:18 pm
Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
- Jan 13th, 2025 3:57 pm
Why Amgen (AMGN) is a Top Value Stock for the Long-Term
- Jan 13th, 2025 2:40 pm
3 High-Yield Dividend Stocks to Buy in 2025
- Jan 13th, 2025 2:00 pm
Viking Therapeutics Starts Mid-Stage Study on Oral Weight-Loss Drug
- Jan 9th, 2025 11:19 am
Scroll